Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01011234

Ligand	Ligand name	Chain	PDB	Tanimoto
Q2Y	4-OXO-3-[2-(5-{[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-METHYL}-THIOPHEN-2-YL)-ACETYLAMINO]-PENTANOIC ACID	A	1RWM	0.71
TFG	2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL	A,B	2VQQ	0.72
TFG	2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL	A,B	2VQO	0.72
TFG	2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL	A	2VQJ	0.72
NZO	nocodazole	A,B	3EE2	0.71
I19	N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine	A	2W17	0.73
GK6	N-{4'-[(cyclopropylmethyl)carbamoyl]-6-methylbiphenyl-3-yl}-2-morpholin-4-ylpyridine-4-carboxamide	A	3D83	0.71
C24	3-({2-[(4-CARBAMIMIDOYL-PHENYLAMINO)-METHYL]-3-METHYL-3H-BENZOIMIDAZOLE-5-CARBONYL}-PYRIDIN-2-YL-AMINO)-PROPIONIC ACID ETHYL ESTER	B,C	1KTS	0.75
STU	STAUROSPORINE	A,B	3CBL	0.7
STU	STAUROSPORINE	A	1QPJ	0.7
STU	STAUROSPORINE	A,B	3CD3	0.7
STU	STAUROSPORINE	A	2ITU	0.7
STU	STAUROSPORINE	A,B	2BUJ	0.7
STU	STAUROSPORINE	A,B	2CLQ	0.7
STU	STAUROSPORINE	A	1XBC	0.7
STU	STAUROSPORINE	A	2ITW	0.7
STU	STAUROSPORINE	A	1E8Z	0.7
STU	STAUROSPORINE	A	1YHS	0.7
STU	STAUROSPORINE	A,B	3D7T	0.7
STU	STAUROSPORINE	A	1QPD	0.7
STU	STAUROSPORINE	A	2Z7R	0.7
STU	STAUROSPORINE	A,B,C,D	2NRY	0.7
STU	STAUROSPORINE	A	1U59	0.7
STU	STAUROSPORINE	A	1NVR	0.7
STU	STAUROSPORINE	A,B,C,D	2OIC	0.7
STU	STAUROSPORINE	A	1AQ1	0.7
STU	STAUROSPORINE	A	1BYG	0.7
STU	STAUROSPORINE	A,B	1SM2	0.7
STU	STAUROSPORINE	X	2DQ7	0.7
STU	STAUROSPORINE	A	3CKX	0.7
STU	STAUROSPORINE	A,B	1Q3D	0.7
STU	STAUROSPORINE	E	1STC	0.7
STU	STAUROSPORINE	A	1OKY	0.7
STU	STAUROSPORINE	A	1WVY	0.7
STU	STAUROSPORINE	A	2HW7	0.7
STU	STAUROSPORINE	A,B	1SNU	0.7
STU	STAUROSPORINE	A	2ITQ	0.7
STU	STAUROSPORINE	A,B,C,D	1NXK	0.7
STU	STAUROSPORINE	A	3BKB	0.7
STU	STAUROSPORINE	A	1XJD	0.7
STU	STAUROSPORINE	A	3FME	0.7
STU	STAUROSPORINE	A,B	2GCD	0.7
STU	STAUROSPORINE	A,B,C	2PZY	0.7
P41	6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine	A	3C5U	0.71
C92	N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide	A,B	3CPB	0.7
HA3	N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide	A,B	2VQV	0.75
HA3	N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide	A	2VQM	0.75
CP9	3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE	A	1TV6	0.73
FR4	1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE	A	1UML	0.72
WSA	5'-O-[(L-TRYPTOPHYLAMINO)SULFONYL]ADENOSINE	A,B,C,D	2YY5	0.71
BTH	4-OXO-3-{6-[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-PENTANOIC ACID	A	1RWO	0.7
PL1	COBALT (III)-DEGLYCOPEPLEOMYCIN	B	1AO1	0.7
4ST	1,2,3,4-TETRAHYDROGEN-STAUROSPORINE	A	2J0J	0.7
4ST	1,2,3,4-TETRAHYDROGEN-STAUROSPORINE	B	2J0M	0.7
4ST	1,2,3,4-TETRAHYDROGEN-STAUROSPORINE	A,B	2J0K	0.7
4ST	1,2,3,4-TETRAHYDROGEN-STAUROSPORINE	A	1YVJ	0.7
4ST	1,2,3,4-TETRAHYDROGEN-STAUROSPORINE	A,B,C	2HZ4	0.7
057	N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide	A,B	3FQH	0.73
FR9	1-[(1R)-3-(6-{[(BENZYLAMINO)CARBONYL]AMINO}-1H-INDOL-1-YL)-1-(HYDROXYMETHYL)PROPYL]-1H-IMIDAZOLE-4-CARBOXAMIDE	A	1O5R	0.71
G95	N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide	A,B	3E87	0.72
L0C	4-{[2-(4-{[(4-FLUOROPHENYL)CARBONYL]AMINO}-1H-PYRAZOL-3-YL)-1H-BENZIMIDAZOL-6-YL]METHYL}MORPHOLIN-4-IUM	A	2W1C	0.71
PMY	AGLYCON OF PEPLOMYCIN	A	1AO4	0.71
PMY	AGLYCON OF PEPLOMYCIN	A	1AO2	0.71
B18	(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE	A,B,C	2PZY	0.73
P40	N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide	A	3DT1	0.73
T42	MORPHOLINO-DIPHENYLALANINE-METHOXYPROPYLBORONIC ACID	H,I	1AI8	0.7
685	2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide	A	3EMG	0.73
626	4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE	A	2OWB	0.7
626	4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE	A,B	2J4Z	0.7
406	N-[3-(4,5'-BIPYRIMIDIN-2-YLAMINO)-4-METHYLPHENYL]-4-{[(3S)-3-(DIMETHYLAMINO)PYRROLIDIN-1-YL]METHYL}-3-(TRIFLUOROMETHYL)BENZAMIDE	A,B	2E2B	0.7
FR8	1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(5-PHENYLPENTANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE	A	1QXL	0.73
FR5	1-((1R)-1-(HYDROXYMETHYL)-3-(6-((3-(1-METHYL-1H-BENZIMIDAZOL-2-YL)PROPANOYL)AMINO)-1H-INDOL-1-YL)PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE	A	1NDZ	0.71
LY4	(9R)-9-[(DIMETHYLAMINO)METHYL]-6,7,10,11-TETRAHYDRO-9H,18H-5,21:12,17-DIMETHENODIBENZO[E,K]PYRROLO[3,4-H][1,4,13]OXADIAZACYCLOHEXADECINE-18,20-DIONE	B	2J2I	0.7
LY4	(9R)-9-[(DIMETHYLAMINO)METHYL]-6,7,10,11-TETRAHYDRO-9H,18H-5,21:12,17-DIMETHENODIBENZO[E,K]PYRROLO[3,4-H][1,4,13]OXADIAZACYCLOHEXADECINE-18,20-DIONE	A	1UU3	0.7
F32	(5S)-5-{4-[(2S)-2-(1H-BENZIMIDAZOL-2-YL)-2-(1,3-BENZOTHIAZOL-2-YLAMINO)ETHYL]PHENYL}ISOTHIAZOLIDIN-3-ONE 1,1-DIOXIDE	A	2CNF	0.7
AIK	N-[3-(DIMETHYLAMINO)PROPYL]-2-({[4-({[4-(FORMYLAMINO)-1-METHYL-1H-PYRROL-2-YL]CARBONYL}AMINO)-1-METHYL-1H-PYRROL-2-YL]CARBONYL}AMINO)-5-ISOPROPYL-1,3-THIAZOLE-4-CARBOXAMIDE	A,B	1RMX	0.71
1PU	1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-PYRIDIN-2-YL-UREA	A	1GII	0.71
1PU	1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-PYRIDIN-2-YL-UREA	A	1GIH	0.71